China Insulin Market Size & Outlook, 2025-2033

China Insulin Market Insights

Based on Reed Intelligence findings, the China Insulin Market reached USD 1166.33 Million in 2024 and is estimated to attain USD 1460.51 Million by 2033.
From 2026 to 2033, the China market is expected to grow at a steady CAGR of 2.52%.
Within the By Source category, Human Insulin dominated in 2024 in terms of market size contribution.
Over the forecast period, Human Insulin is forecasted to deliver the fastest growth, positioning it as the most lucrative By Source segment.

Other Key Findings

China contributed 5.83% to the global Insulin Market size in 2024.
By 2033, United States is forecasted to remain the largest global market for Insulin Market.
In Asia Pacific, China is projected to capture the leading share of market size by 2033.
Among Asia Pacific markets, Singapore is expected to post the fastest growth, reaching USD 116.46 Million by 2033.

Report Summary

Report Scope	Details
Base Year for Study	2024
Study Period	2021-2033
Historical Period	2021-2023
Forecast Period	2025-2033
Market Size In 2024	USD 1166.33 Million
Market Size In 2033	USD 1460.51 Million
Largest segment	Human Insulin
Units	Revenue in USD Million
CAGR	2.52% (2025-2033)
Segmnetation Covered
By Source	Human Insulin Analog Insulin
By Type	Short Acting Insulin Intermediate Acting Insulin Long-Acting Insulin Fast-Acting Insulin
By Application	Type II Diabetes, Type I Diabetes, Gestational Diabetes Pre-diabetes
By Delivery System	Syringes Pens Pumps
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

China Insulin Market By Source 2025-2033 (USD Million)

By Source	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Human Insulin	XX.x	XX.x	XX.x	659.09	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Analog Insulin	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

China Insulin Market By Type 2025-2033 (USD Million)

By Type	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Short Acting Insulin	XX.x	XX.x	XX.x	469.1	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Intermediate Acting Insulin	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Long-Acting Insulin	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Fast-Acting Insulin	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

China Insulin Market By Application 2025-2033 (USD Million)

By Application	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Type II Diabetes,	XX.x	XX.x	XX.x	496.51	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Type I Diabetes,	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Gestational Diabetes	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Pre-diabetes	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

China Insulin Market By Delivery System 2025-2033 (USD Million)

By Delivery System	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Syringes	XX.x	XX.x	XX.x	571.15	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Pens	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Pumps	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.